Search research articles
Contact Us
Filters
Showing results (181-190 of 186) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 186 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2024
Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung Cancer
Mehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann, et al.
The Journal of Biological Chemistry
|
January 28, 2015
Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancer
Fernanda I Staquicini, Ming D Qian, Ahmad Salameh, et al.
Investigational New Drugs
|
January 25, 2024
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort
Oluwadunni E Emiloju, Jun Yin, Emily Koubek, et al.
Journal for Immunotherapy of Cancer
|
January 28, 2022
Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10<sup>+</sup> advanced non-small cell lung cancer
George R Blumenschein, Siddhartha Devarakonda, Melissa Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2026
Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators
Deborah B Doroshow, Ticiana A Leal, Saiama N Waqar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 2, 2016
Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?
Paul A Bunn, John D Minna, Alexander Augustyn, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 186) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 186 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2024
Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung Cancer
Mehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann, et al.
The Journal of Biological Chemistry
|
January 28, 2015
Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancer
Fernanda I Staquicini, Ming D Qian, Ahmad Salameh, et al.
Investigational New Drugs
|
January 25, 2024
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort
Oluwadunni E Emiloju, Jun Yin, Emily Koubek, et al.
Journal for Immunotherapy of Cancer
|
January 28, 2022
Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10<sup>+</sup> advanced non-small cell lung cancer
George R Blumenschein, Siddhartha Devarakonda, Melissa Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2026
Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators
Deborah B Doroshow, Ticiana A Leal, Saiama N Waqar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 2, 2016
Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?
Paul A Bunn, John D Minna, Alexander Augustyn, et al.
Page
of 19